Erratum: Author Correction: Breast-cancer-specific mortality in patients treated based on the 21-gene assay: a SEER population-based study

Affiliations

¹ 1National Cancer Institute, Bethesda, MD USA.
² 2Genomic Health, Inc., Redwood City, CA USA.
³ 3IMS, Inc., Calverton, MD USA.
⁴ 4University of California, San Francisco, CA USA.
⁵ Public Health Institute, Cancer Registry of Greater California, Sacramento, CA USA.
⁶ 6University of Southern California, Los Angeles, CA USA.
⁷ 7Cancer Prevention Institute of California, Fremont, CA USA.
⁸ 8Stanford Cancer Institute, Stanford, CA USA.
⁹ 9University of Hawaii Cancer Center, Honolulu, HI USA.
¹⁰ 10Department of Epidemiology, University of Iowa, Iowa City, IA USA.
¹¹ 11Connecticut Tumor Registry, Connecticut Department of Public Health, Hartford, CT USA.
¹² 12Karmanos Cancer Institute, Wayne State University, Detroit, MI USA.
¹³ 13Cancer Surveillance System, Fred Hutchinson Cancer Research Center, Seattle, WA USA.
¹⁴ 14Rutgers School of Public Health, Piscataway, NJ USA.
¹⁵ 15Cancer Institute of New Jersey, New Brunswick, NJ USA.
¹⁶ 16Utah Cancer Registry, Department of Internal Medicine, and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT USA.
¹⁷ 17University of Kentucky, Markey Cancer Center, Lexington, KY USA.
¹⁸ 18Emory University, Atlanta, GA USA.
¹⁹ 19New Mexico Tumor Registry, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM USA.
²⁰ 20Louisiana State University Health Sciences Center, New Orleans, LA USA.

Published Erratum

Valentina I Petkov et al. NPJ Breast Cancer. 2018.

. 2018 Jul 6:4:17.

doi: 10.1038/s41523-018-0069-3. eCollection 2018.

¹ 1National Cancer Institute, Bethesda, MD USA.
² 2Genomic Health, Inc., Redwood City, CA USA.
³ 3IMS, Inc., Calverton, MD USA.
⁴ 4University of California, San Francisco, CA USA.
⁵ Public Health Institute, Cancer Registry of Greater California, Sacramento, CA USA.
⁶ 6University of Southern California, Los Angeles, CA USA.
⁷ 7Cancer Prevention Institute of California, Fremont, CA USA.
⁸ 8Stanford Cancer Institute, Stanford, CA USA.
⁹ 9University of Hawaii Cancer Center, Honolulu, HI USA.
¹⁰ 10Department of Epidemiology, University of Iowa, Iowa City, IA USA.
¹¹ 11Connecticut Tumor Registry, Connecticut Department of Public Health, Hartford, CT USA.
¹² 12Karmanos Cancer Institute, Wayne State University, Detroit, MI USA.
¹³ 13Cancer Surveillance System, Fred Hutchinson Cancer Research Center, Seattle, WA USA.
¹⁴ 14Rutgers School of Public Health, Piscataway, NJ USA.
¹⁵ 15Cancer Institute of New Jersey, New Brunswick, NJ USA.
¹⁶ 16Utah Cancer Registry, Department of Internal Medicine, and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT USA.
¹⁷ 17University of Kentucky, Markey Cancer Center, Lexington, KY USA.
¹⁸ 18Emory University, Atlanta, GA USA.
¹⁹ 19New Mexico Tumor Registry, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM USA.
²⁰ 20Louisiana State University Health Sciences Center, New Orleans, LA USA.

Abstract

[This corrects the article DOI: 10.1038/npjbcancer.2016.17.].

Breast-cancer-specific mortality in patients treated based on the 21-gene assay: a SEER population-based study.
Petkov VI, Miller DP, Howlader N, Gliner N, Howe W, Schussler N, Cronin K, Baehner FL, Cress R, Deapen D, Glaser SL, Hernandez BY, Lynch CF, Mueller L, Schwartz AG, Schwartz SM, Stroup A, Sweeney C, Tucker TC, Ward KC, Wiggins C, Wu XC, Penberthy L, Shak S. Petkov VI, et al. NPJ Breast Cancer. 2016 Jun 8;2:16017. doi: 10.1038/npjbcancer.2016.17. eCollection 2016. NPJ Breast Cancer. 2016. PMID: 28721379 Free PMC article.